IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aisling Capital Management LP

Q4 2023 Holdings

Filed 2024-02-07 | 16 holdings | $335.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
BridgeBio Pharma Inc. (Bbio)(BBIO)COM10806X102$245.0M6,068,12573.1%
Verona Pharma plc (Vrna)(VRNA)SPONSORED ADS925050106$22.2M1,115,3526.6%
Syndax Pharmaceuticals, Inc. (Sndx)(SNDX)COM87164F105$22.2M1,025,0006.6%
Biomea Fusion Inc (Bmea)(BMEA)COM09077A106$11.6M798,7573.5%
Compass Pathways Plc (Cmps)(CMPS)SPONSORED ADS20451W101$8.4M964,5002.5%
Monte Rosa Therapeutics Inc (Glue)(GLUE)COM61225M102$8.3M1,472,3312.5%
Nuvation Bio Inc. (Nuvb)(NUVB)COM CL A67080N101$3.8M2,541,0091.1%
Spruce Biosciences, Inc. (Sprb)COM85209E109$3.5M1,205,5111.1%
Poseida Therapeutics Inc. (Pstx)(PSTXUSD)COM73730P108$3.5M1,043,2671.0%
Marker Therapeutics, Inc. (Mrkr)(MRKR)COM57055L206$1.7M314,2860.5%
Elevation Oncology Inc (Elev)COM28623U101$1.5M2,834,9100.5%
Reneo Pharmaceuticals Inc (Rphm)(RPHM)COM75974E103$1.4M886,0750.4%
Avrobio, Inc. (Avro)COM05455M100$1.4M1,009,7790.4%
Aclaris Theraputics Inc (Acrs)(ACRS)COM00461U105$456.2K434,4550.1%
Viracta Therapeutics Inc (Virx)COM92765F108$164.5K288,5710.0%
Atreca Inc. (Bcel)(BCELUSD)CL A COM04965G109$51.2K387,6530.0%